Bionano Genomics (MEX:BNGO) FFO


MEX:BNGO Bionano Genomics Inc MEX:BNGO
61 GF Score
Price MXN19.92
GF Value MXN27.07
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bionano Genomics FFO?

FFO (Funds from operations) only applies to REITs.

MEX:BNGO
61GF Score
Bionano Genomics Inc MEX:BNGO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bionano Genomics (MEX:BNGO) Overvalued in 2026?

Based on GuruFocus' analysis, Bionano Genomics stock appears to be undervalued. The current stock price of MXN19.92 is trading 26.4% below its estimated GF Value™ of MXN27.07. GuruFocus considers Bionano Genomics to be Modestly Undervalued.

Key valuation signals for MEX:BNGO:

  • FFO:
  • GF Value™: MXN27.07 vs. price of MXN19.92 (26.4% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the MEX:BNGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bionano Genomics Business Description

Other Exchanges BNGO:USA
Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
61GF Score

Get the complete analysis for MEX:BNGO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN19.92
Price
MXN27.07
GF Value